CompoAtlas

+fibre aux baies

Food supplement declared in France, decision dated 27 September 2026

+fibre aux baies (fruttberry) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition.

Brand
fruttberry
Food business operator placing the product on the market
UAB Fruttberry
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Poudre
Daily dose
15 g (3 x 5 g) par jour
Directions for use
5 g (une cuillère à café) trois fois par jour avant le repas (15 g par jour, trois cuillères à café), mélangé dans un verre d'eau, de jus ou toute autre boisson de son choix. Boire ensuite suffisamment d'eau supplémentaire (1 à 2 verres) afin de garantir que le produit atteigne correctement l'estomac. Faire preuve de prudence en cas de troubles de la déglutition, en raison d'un risque d'étouffement.
Intended populations
Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Transit
Flavourings
fraise, cassis

Declaration 376966, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Plantago ovata Forssk.TégumentPoudre (de plantes séchées ou broyées)7,500 mg
Fragaria × ananassa (Duchesne ex Weston) Duchesne ex RozierFruitPoudre (de plantes séchées ou broyées)1,800 mg
Ribes nigrum L.FruitPoudre (de plantes séchées ou broyées)1,200 mg

Substances

NamePer day
glucomannane1,500 mg

Other active ingredients

NamePer day
Inulinenot declared

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière recommandée. Un complément alimentaire ne doit pas être utilisé comme substitut d'une alimentation variée. Tenir hors de portée des enfants. En cas de troubles de la déglutition : utiliser avec précaution en raison d'un risque d'étouffement. Déconseillé aux enfants, aux femmes enceintes et aux femmes allaitantes sans avis médical préalable. Une alimentation variée et équilibrée ainsi qu'un mode de vie sain sont importants. À conserver dans un endroit sec, à une température ne dépassant pas 25 °C.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • glucomannane
    Read the warning, when it applies and the studies cited

    GLUCOMANNAN

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (FDA 2023).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (UpToDate 2023; EMA 2013; Chen et al. 2003; Vuksan et al. 2001).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation relief.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you have difficulty swallowing (FDA 2023; Sweetman 2007; Vanderbeek et al. 2007; Henry et al. 1986).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2013; Pray 2006; Berardi et al. 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2013).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product you may experience temporary gas and bloating (Sood et al. 2008).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : fruttberry

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line